Symbiotic Capital

Symbiotic Capital Management Co. LLC is a new investment advisory firm specializing in life science credit investments, founded in September 2022 and located in Los Angeles, California. The firm aims to be the preferred credit partner for innovative life science companies, offering advisory services to various life science credit funds. As of December 2024, Symbiotic Capital has $839,442,588 in discretionary assets under management. The firm charges an annual management fee of 1.75% per annum and may receive performance-based compensation. Symbiotic Capital focuses on extending senior secured term loans to high-quality life science companies, aiming for compelling risk-adjusted returns with structural downside protections. The firm conducts thorough due diligence and risk management to mitigate investment risks. Symbiotic Capital does not participate in wrap fee programs, and it has investment discretion over client accounts. The firm has no disciplinary events to disclose and does not have custody over client funds. Symbiotic Capital has a Code of Ethics in place and does not have arrangements for client referrals or compensation. The firm does not anticipate voting on client securities or engaging in proxy voting at this time.